Madison El-Saadi
Stock Analyst at B. Riley Securities
(3.22)
# 960
Out of 5,152 analysts
13
Total ratings
53.85%
Success rate
18.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $63.60 | +58.81% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $7.91 | +76.99% | 2 | Dec 31, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $21 → $50 | $25.82 | +93.65% | 2 | Dec 15, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $13.20 | +180.30% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $161.46 | +10.86% | 1 | Oct 1, 2025 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $24 → $26 | $17.24 | +50.86% | 3 | May 16, 2025 |
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $63.60
Upside: +58.81%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.91
Upside: +76.99%
Capricor Therapeutics
Dec 15, 2025
Reiterates: Buy
Price Target: $21 → $50
Current: $25.82
Upside: +93.65%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $13.20
Upside: +180.30%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $161.46
Upside: +10.86%
Eton Pharmaceuticals
May 16, 2025
Reiterates: Buy
Price Target: $24 → $26
Current: $17.24
Upside: +50.86%